baber/WOPTO huggingface dataset:
Patent EP-0788344-B1 (EP)
Inventor: WICTORIN LENNART
IPC: A61K6/891
Filed: 1995-05-05
Granted: 2000-10-04
Abstract: A photopolymerizable epoxy-monomer, preferably 3,4-epoxycyclohexyl-methyl-3,4-epoxy-cyclohexane-carboxylate or bis-(3,4-epoxycyclohexyl-adipate) is included in photo-hardening compositions, preferably for dental use. The compositions exhibit no hardening shrinkage, or very little hardening shrinkage, and high mechanical strength.
Patent EP-0729430-B1 (EP)
Inventor: HARRIS RANDALL LEE
IPC: B65D71/24
Filed: 1995-08-15
Granted: 2003-12-10
Abstract: A basket-style carrier which exposes much of the end packaged articles. The carrier has narrow side panels which, with partition straps, form article receiving cells. End cells are formed by the partition straps, side straps extending out from the side panels and end straps connected to the side straps. The partition straps and the end straps are connected to a central support panel, which includes a handle panel portion. The end straps and side straps contact only small portions of the articles, allowing the remainder of the end articles to be viewed.
Patent EP-0731990-B1 (EP)
Inventor: SAERKKAE VELI-MATTI
IPC: H01P7/10
Filed: 1995-10-04
Granted: 2000-03-01
Abstract: PCT No. PCT/FI95/00548 Sec. 371 Date Jun. 4, 1996 Sec. 102(e) Date Jun. 4, 1996 PCT Filed Oct. 4, 1995 PCT Pub. No. WO96/11512 PCT Pub. Date Apr. 18, 1996A dielectric resonator including a cylindrical dielectric resonator body having a concentric cylindrical recess. A resonance frequency controller includes an adjustment mechanism and a cylindrical dielectric adjustment body which is movable by means of the adjustment mechanism in the axial direction inside the recess of the resonator body for adjusting the resonance frequency. The frequency controller further includes a dielectric fine adjustment body attached to the adjustment mechanism and arranged inside the adjustment body so that the projection of the fine adjustment body at the end of the adjustment body within the recess in the resonator body can be adjusted by a movement of the adjustment mechanism. Thus, the frequency controller has two slopes of adjustment, whereby the adjustment is fast owing to the movement of both adjustment bodies and also extremely accurate owing to the fine adjustment function, which is achieved when the smaller adjustment body is moved alone.
Patent EP-0796168-B1 (EP)
Inventor: LOEWENTHAL HORST
IPC: B29C65/00
Filed: 1995-12-01
Granted: 1998-05-20
Abstract: Mittels Kurbeltrieben (15-18) sind beidseits einer Mittelebene (4) eines zugeführten Verpackungsschlauches (1) zwei Halter (27-30) parallel umlaufend angetrieben. In den Haltern (27-30) ist eine Siegelbacke (37) bzw. Gegenbacke (38) vertikal verschiebbar geführt und durch je eine Feder (41) gegen einen Anschlag (44) vorbelastet. Von den Backen (37, 38) stehen seitlich Anschlagrollen (62)ab, die vor dem Aufeinandertreffen der Backen (37, 38) auf Auflageleisten (48, 49) auflaufen. Dabei werden die Auflageleisten (48, 49) durch eine Steuereinrichtung (54) derart gegeneinander bewegt, dass die Vertikalkomponenten der Backenbewegungen gesteuert verzögert werden. Vor dem Auseinanderfahren der Backen (37, 38) werden sie in umgekehrter Weise auf die erforderliche Vertikalgeschwindigkeit beschleunigt, damit sie sanft am Anschlag (44) anschlagen. Die Vorrichtung arbeitet im Betrieb leise, ist materialschonend und kann an unterschiedliche Betriebsbedingungen angepasst werden.
Patent EP-0739222-B1 (EP)
Inventor: FUNDERBURK JEFFERY V
IPC: A61M39/14
Filed: 1995-10-12
Granted: 1998-03-11
Abstract: Un raccord rapide (10) destiné à être utilisé dans un système de perfusion de médicaments permet de déconnecter provisoirement et de raccorder ultérieurement une pompe à perfusion (12) à un patient sans avoir à retirer de canule (18) pour perfusion transcutanée. Le raccord monté dans le prolongement d'une longueur de tube de perfusion (14), comporte un élément femelle pourvu d'une aiguille rentrée à l'intérieur et conçu pour se raccorder par coulissement à un élément mâle pourvu d'une membrane (48) auto-obturante. Des pattes radiales situées sur l'élément mâle coulissent librement dans des fentes (10) à ouverture longitudinale de l'élément femelle. L'élément mâle peut tourner afin de positionner les pattes (48) selon un ajustement serré au-delà de surfaces à came entaillées de sorte qu'elles s'alignent avec des orifices à ouverture radiale de l'élément femelle. Lorsqu'ils sont raccordés, les éléments mâle et femelle sont effectivement bloqués contre une séparation longitudinale. Toutefois, les éléments mâle et femelle peuvent être séparés sans risque et facilement, et sans appliquer de forces sensiblement longitudinales, par rotation de l'élément mâle, qui replace ainsi les pattes dans l'alignement des fentes à ouverture longitudinale de l'élément femelle.
Patent EP-0728843-B1 (EP)
Inventor: HABENSTEIN KLAUS DR
IPC: C12Q1/54
Filed: 1996-01-23
Granted: 2003-04-23
Abstract: Reagent for use with a redox detection system, comprises periodate ions and a complex former of formula (I): ÄZ(Rn)Ü<+> A<-> (I). Z = P, N, As, S or Se; n = 4 (when Z is P, N or As) or 3 (when Z = S or Se); R = phenyl, benzyl, alkyl or cycloalkyl (each opt. substd. by 1-8C alkyl); A<-> = Br<->, I<->, Cl<-> or F<->.
Patent EP-0728840-B1 (EP)
Inventor: HOSHINO TATSUO
IPC: C12P19/02
Filed: 1996-02-17
Granted: 2007-04-25
Abstract: D-sorbitol dehydrogenase in purified form, which catalyzes the oxidation of D-sorbitol to L-sorbose, has a molecular structure consisting of homologous subunit of molecular weight 79,000+/-5,000, a substrate specificity for polyols and an optimum pH of 6.0-7.0. Said D-sorbitol dehydrogenase is producible by a process comprising cultivating a microorganism belonging to the genus Gluconobacter or Acetobacter, or a mutant or variant thereof, which is capable of producing the D-sorbitol dehydrogenase in the cells and isolating it from the cells, e.g. by disrupting the cells and isolation from cell-free extract of the disrupted cells. The so-isolated D-sorbitol hydrogenase is useful for catalyzing the oxidation of D-sorbitol to L-sorbose, the latter being an important intermediate for the production of vitamin C.
Patent EP-0751197-B1 (EP)
Inventor: BLUM HARALD DR
IPC: C09D175/06
Filed: 1996-06-13
Granted: 2002-09-18
Abstract: An aq. binder comprises a combination of: (A) 65-97 wt.% aq. polyol of 23 degrees C viscosity of 25-15,000 mPa.s; and (B) 3-35 wt.% polyisocyanate component of 23 degrees C viscosity of 50-10,000 mPa.s contg. at least one organic polyisocyanate. The equiv. ratio of NCO gps. in (A):OH gps. in (B) = 0.3-2:1. The novel feature is that component: (A) comprises a mixt. of: (A1) an OH contg. aq. polyester dispersion or soln. comprising an OH-, carboxylate- and/or sulphonate-gp.-contg. polyester resin of ave. mol.wt. (Mw) 1,000-40,000, OH No. 15-100 mg KOH/g dispersion or soln. and acid no. (COOH or COOH + SO3H) 2-30 mg KOH/g, this polyester being the reaction prod. of components (a1)-(a4) as listed below; and (A2) a physically-drying aq. dispersion of a polyurethane contg. carboxylate and/or sulphonate gps. Reaction components (a1)-(a4) are as follows: (a1) 65-100 wt.% polyester pre-condensate from (i) 0-40 wt.% monocarboxylic acids, (ii) 20-65 wt.% di-, tri- and/or tetra-functional alcohols, (iii) 20-60 wt.% di- and/or tri-functional carboxylic acids or anhydrides and (iv) 0-10 wt.% sulphonate-, carboxyl- and/or OH-contg. component; (a2) 0-15 wt.% carboxylic acid anhydride or hydroxycarboxylic acid; (a3) 0-22 wt.% of an at least difunctional isocyanate component; and (a4) 0-8 wt.% mono-, di- and/or tri-functional substance with OH and/or amino gps. Also claimed is the prodn. which involves introducing the various auxiliaries or additives for (A) prior to polyisocyanate (B), such introduction being by simple stirring such that rather special appts. nor a further viscosity adjustment is required.
Patent EP-0738859-B1 (EP)
Inventor: KAWAGUCHI SUSUMU
IPC: F04B39/02
Filed: 1992-12-02
Granted: 2000-05-31
Abstract: A refrigeration device has a refrigeration circuit which uses a hydrofluorocarbon refrigerant and comprises a compressor (1), an evaporator (4) and an accumulator (5), in which the compressor uses a lubricating oil (e.g. hard akyl benzene oil) insoluble with the refrigerant. A compressor suction pipe (7) has an oil return hole (8) in the upper end portion portion thereof  and is inserted into the accumulator from below, and the evaporator outlet is connected to the upper end of the accumulator. <IMAGE>
Patent EP-0774435-B1 (EP)
Inventor: GIACHETTI FRANCO
IPC: B65H16/02
Filed: 1996-11-07
Granted: 2002-02-13
Abstract: The present invention relates to an apparatus (1) for automatically selecting and loading cloth pieces (11) on spreading machines (2), which apparatus (1) comprises a loading/unloading assembly (10) for loading/unloading cloth pieces (11) on/from a spreading machine (2), designed for taking up the cloth pieces (11) and supplying said cloth pieces (11), according to a preset program, to a storing section (20), upstream of which a further loading/unloading assembly (40) is provided for said storing section (20). <IMAGE>
Patent EP-0801869-B1 (EP)
Inventor: PYKAELISTOE MIKA
IPC: H04Q3/00
Filed: 1996-01-03
Granted: 2003-04-02
Abstract: Dans un procédé, conformément à un avis d'un réseau intelligent, lorsqu'un abonné B a raccroché le combiné téléphonique, un Point de Commutation de Service (SSP) envoie un message à un Point de Contrôle de Service (SCP) concernant le raccrochage. Le SCP répond par une demande afin de déconnecter le tronçon B. Une demande séparée augmente la vitesse de numérotation inutile. Selon un autre procédé connu, après qu'un abonné B ait raccroché, une minuterie se met en route et le tronçon B est déconnecté uniquement appels une durée définie. Ce temps d'attente est ennuyeux pour l'abonné A, notamment lorsqu'il a de nombreux appels à passer. Selon le procédé de l'invention, un abonné A peut effectuer un appel continu sans attendre ou sans faire de vitesse de numérotation inutile de sorte que, après que la Fonction de Contrôle de Service (SCF) ait reçu des informations concernant l'interruption de l'appel, celui-ci envoie un message à une Fonction de Commutation de Service (SSF) contenant une demande afin de récupérer la numérotation effectuée par l'abonné A en relation avec un nouvel abonné B. La Fonction de Commutation de Service (SSF) commande le réseau téléphonique pour couper la liaison avec un abonné B et créer une liaison pour un nouvel abonné B.
Patent EP-0809635-B1 (EP)
Inventor: WANG KEVIN KA-WANG
IPC: A61P21/00
Filed: 1996-01-24
Granted: 2001-10-04
Abstract: The invention covers a novel series of  alpha -substituted hydrazides that inhibit both calpain I and calpain II. They are non-peptide irreversible active site inhibitors of calpain. The compounds are useful in the treatment of neurodegenerative disorders including cerebrovascular disorders, brain injury, spinal cord, and peripheral nerve injury, cardiac infarction, cataracts, inflammation, restenosis, muscular dystrophy, and platelet aggregation. Pharmaceutical compositions, methods of using processes for preparing and novel intermediates useful in the processes are also disclosed.
Patent EP-0813538-B1 (EP)
Inventor: LEVINSON DOUGLAS A
IPC: A61P37/02
Filed: 1996-03-01
Granted: 2006-06-07
Abstract: The present invention relates to methods and compositions for the treatment of immune disorders, especially T helper (TH) cell and TH cell-like related disorders. First, genes are identified and described which are differentially expressed within and among TH cells and TH cell subpopulations. Second, genes are identified and described which are differentially expressed within TH cell subpopulations in TH cell subpopulation-related disorders. The modulation of the expression of the identified genes and/or activity of the identified gene products can be utilized therapeutically to ameliorate immune disorder symptoms and to modulate TH cell responsiveness, for example, responsiveness to antigen. Further, the identified genes and/or gene products can be used to diagnose individuals exhibiting or predisposed to such immune disorders. Still further, the identified genes and/or gene products can be used to detect TH cell responsiveness, for example, responsivenem to antigen.
Patent EP-0760240-B1 (EP)
Inventor: LAZARO FLORES CONSUELO
IPC: A23L27/20
Filed: 1996-04-10
Granted: 2005-10-12
Abstract: The present invention is based on the discovery of the potent action that certain alcaloids with an eburnamenine nucleus have when they are administered in association with compounds having a xantine structure. A synergic potent action in the cognoscitive capacity is obtained and, consequently the cerebral activity is reinforced in general in the short and long term following the oral administration of the patented composition. The disclosed composition contains quantities comprised between 0.5 and 10 mg of alcaloids or extract of alcaloids of the eburnamenine type per 100 ml of beverage of cola, lemon, cocoa, ginseng, tonic water, coffee or any other beverage obtained from extracts, in quantities comprised between 0.4 and 30 mg of alcaloids or extracts, of alcaloids of the eburnamenine type per each 5-20 g of dry, semi-dry or wet extract of coffee, cola, cocoa, tea, ginseng, tonic water or any other extract for beverages.
Patent EP-0837679-B1 (EP)
Inventor: PHILLIPS JAMES G
IPC: C07D233/60
Filed: 1996-05-29
Granted: 2001-10-24
Abstract: The present invention provides compounds having H3 histamine receptor antagonist activity of the general formula:    <IMAGE>  (1.0)  where X is H, A is -CH2CH2-, -COCH2-, -CONH-, -CON(CH3)-, -CH=CH-, -C 3BOND C-, -CH2-NH-, -CH2-NCH3-, -CH(OH)CH2-, -NH-CH2-, -N(CH3) -CH2-, -NHSO2-, -CH2O-, -CH2S-, CH2SO2-, or -CH2S(O)-; R2 is a hydrogen or a methyl or ethyl group; R3 is a hydrogen or a methyl or ethyl group; n is 0, 1, 2, 3, 4, 5, or 6; and R1 is selected from the group consisting of (a) C3 to C8 cycloalkyl; (b) H; (c) phenyl or substituted phenyl; (d) alkyl; (e) heterocyclic; and (f) bicyclic alkyl; and when X is NH2, NHCH3, N(CH3)2, OH, OCH3, NHR4, OR4, SH, SR4, or SO2R4; A is -NHCO-, -N(CH3)-CO-, -NHCH2-, -N(CH3)-CH2-, -NHSO2-, -CH=CH-, -CH=CHF-, -COCH2-, -CH2CH2-, -CH(OH)CH2-, or -C 3BOND C-; R2 is a hydrogen or a methyl or ethyl group; R3 is a hydrogen or a methyl or ethyl group; n is 0, 1, 2, 3, 4, 5, or 6; R1 is selected from the group consisting of (a) C3 to C8 cycloalkyl; (b) H; (c) phenyl or substituted phenyl; (d) alkyl; (e) heterocyclic; and (f) bicyclic alkyl and R4 is designated to mean that X is contained within a ring such as octahydroindole.
Patent EP-0770820-B1 (EP)
Inventor: SEKIGUCHI YOSHITOSHI
IPC: F23G5/02
Filed: 1996-05-15
Granted: 2001-09-26
Abstract: Combustible is crushed and dried, and metal and non-combustible are removed from the crushed coarse combustible. Then the crushed coarse combustible is subjected to secondary crushing to be separated into a coarse particle combustible and fluff which is a fine particle combustible. The coarse particle combustible thus separated is charged onto a fire grate (2) of an incinerator (1) to be subjected to plane combustion in a primary chamber (4). On the other hand, fluff is subjected to space combustion in a secondary chamber (7) by a fluff burner (5) for combustion, so that the combustible is incinerated. Accordingly, refuse containing a great deal of plastics which is almost formed into fluff is efficiently treated to increase an amount of refuse incinerated as a whole. <IMAGE>
Patent EP-0835152-B1 (EP)
Inventor: VISCONTI PETER L
IPC: A61M39/06
Filed: 1996-05-24
Granted: 2002-04-24
Abstract: The present invention provides thoracentesis catheter instruments having self-sealing valves utilized in invasive medical procedures. The thoracentesis instruments provide automatic sealing of a flow path by the self-sealing valve upon removal of a needle from a catheter. A drainage flow path to a pleural cavity is established by manual movement of another valve. The self-sealing valve prevents insertion of the needle through the valve and the catheter.
Patent EP-0831775-B1 (EP)
Inventor: BOWMAN LYLE M
IPC: A61K9/00
Filed: 1996-05-29
Granted: 2002-09-11
Abstract: Ophthalmic methods and compositions are disclosed where particles of the dispersed phase of emulsions are themselves dispersed and stably maintained in physical separation by lightly crosslinked, water swellable polymers present in an aqueous polymeric system formulated for administration to the eye in drop or ribbon form. Medicament is dissolved in that dispersed phase is delivered over a sustained release period.
Patent EP-0832100-B1 (EP)
Inventor: CAMPBELL DAVID A
IPC: C07K5/06
Filed: 1996-06-06
Granted: 2000-04-05
Abstract: Disclosed are novel inhibitors of metalloproteases, in particular matrix metalloproteases. The disclosed inhibitors are mercaptoketone and mercaptoalcohol compounds which are useful in pharmaceutical compositions and methods for treating or controlling disease states or conditions which involve tissue breakdown, for example, arthropathy, dermatological conditions, bone resorption, inflammatory diseases, and tumor invasion and in the promotion of wound healing.
Patent EP-0846118-B1 (EP)
Inventor: DAUGAN ALAIN CLAUDE-MARIE
IPC: A61K31/495
Filed: 1996-07-11
Granted: 2002-05-02
Abstract: Composé de formule (I) et ses solvates, dans laquelle R0 représente hydrogène, halogène ou alkyle en C¿1-6; R?1 représente hydrogène ou alkyle en C¿1-6; R?2 représente le noyau bicyclique (1) pouvant être éventuellement substitué par un ou plusieurs groupes choisis entre halogène et alkyle en C¿1-3?; et R?3¿ représente hydrogène ou alkyle en C¿1-3?. Un composé de la présente invention constitue un inhibiteur puissant et sélectif de PDE spécifique de GMP cyclique présentant une utilité dans divers domaines thérapeutiques dans lesquels une telle inhibition est avantageuse.
Patent EP-0862369-B1 (EP)
Inventor: CAIN FREDERICK WILLIAM
IPC: A23L33/12
Filed: 1996-11-12
Granted: 2001-03-07
Abstract: PCT No. PCT/EP96/05025 Sec. 371 Date May 26, 1998 Sec. 102(e) Date May 26, 1998 PCT Filed Nov. 12, 1996 PCT Pub. No. WO97/19601 PCT Pub. Date Jun. 5, 1997Fish oil concentrates, having: </=40% of long chain poly unsaturated fatty acids <20% of saturated fatty acids (C14-C18) <15% oleic acid <12% C16:1-fatty acid and with a weight-ratio: can be obtained by a process involving the following steps subjecting a fish oil to an enzymic conversion removing free fatty acids or esters from conversion-product subjecting product of above to enzymic hydrolysis, using specific lipase or partial glyceride-specific lipase wash and dry product re-esterify dried product.
Patent EP-0811656-B1 (EP)
Inventor: SHIBUYA TAKASHI
IPC: C03C27/12
Filed: 1996-12-25
Granted: 2004-04-28
Abstract: A double-glazed unit comprising at least two flat glasses arranged in such a manner that they face with each other across a spacing layer formed by resin spacers which are made of a thermoplastic resin composition comprising 50 to 98 wt.% of a butyl rubber and 2 to 50 wt.% of a crystalline polyolefin, each percentage being based on the total amount of the rubber and the polyolefin, and which exhibit a JIS A hardness of 10 to 90 at 25 °C.
Patent EP-0792898-B1 (EP)
Inventor: GOEBEL ARMIN
IPC: C08J3/07
Filed: 1997-02-22
Granted: 2000-12-13
Abstract: Preparing a dispersion of hydroxy-functional binder containing (non)ionic, hydrophilic and/or neutralisable acidic or basic groups, used as binders for aqueous two-component coatings or aqueous dispersions containing standard lacquer additives, comprises: (a) mixing the hydroxy-functional binder, optionally present in an organic solvent phase with at least some of the standard lacquer additives in a non-aqueous phase; (b) partially neutralising acidic or basic groups at least before, during or after mixing with the additive; (c) homogenising and converting the resulting mixture into an aqueous phase; and (d) degrading any excess additive remaining. The use of these dispersions as binders or for the preparation of binders for aqueous two-component coatings is also claimed. Preferably the additives include light protection agents, processing aids, thixotropic agents, thickeners, anti-foaming agents, wetting agents, skin formation prevention agents, anti-oxidants, anti-flocking agents, matting agents, adhesion promoting agents, structure additives, gloss improving additives, catalysts and solvents. Acidic and basic groups are neutralised by adding neutralising agent after the binder/additive mixture has been homogenised and then the at least partially neutralised binder mixture is re-homogenised. Homogenisation is carried out at elevated temperature. At least one pigment and/or filler are added at the same time as the additives.
Patent EP-0803984-B1 (EP)
Inventor: CLARKE DAVID STUART
IPC: H03L7/093
Filed: 1997-03-06
Granted: 2003-07-09
Abstract: Amplifier means 5a, 5b e.g. an operational amplifier, for a phase-locked loop employing charge pump 7 for synthesizing RF channels permits a low supply voltage to be used by splitting the amplifier into two stages 5a, 5b. The output at 5a may be a high impedance common emitter pair of complementary transistors allowing a wide voltage swing and part 5b may be an operational amplifier with resistive feedback to provide gain less than unity and a low impedance output to provide feedback around the loop filter to source the current from charge pump 7 entering inverting input of the first stage 5a. Alternatively, stages 5a, 5b may be reversed. <IMAGE>
Patent EP-0799620-B1 (EP)
Inventor: PARIKH INDU
IPC: A61K31/00
Filed: 1997-04-03
Granted: 2004-03-03
Abstract: An oil-in-water emulsion composed of an aqueous phase and an oil phase which comprises a synthetic triglyceride in which is dissolved cyclosporin and phospholipid, and optionally free fatty acid or a salt thereof, provides a stable pharmaceutical composition.
Patent EP-0822290-B1 (EP)
Inventor: BERHAUT JEAN-BERNARD
IPC: D21H17/10
Filed: 1997-07-24
Granted: 2003-05-28
Abstract: Fireproof paper with increased resistance, notably conforming to classification M1, comprises at least cellulose fibres and at least incombustible fillers with flame retardant properties, dry ratio, R, of charges to fibres = 1-9, and 1-15 pts.wt. halogenated polymer(s) in form of stable aqueous dispersion to form the base mixture; and 0.1-10 wt.% fireproof salt(s) soluble or dispersible in aqueous medium; dry weight measured relative to paper at 100 degrees C.
Patent EP-0946597-B1 (EP)
Inventor: HLYNIANSKI DANIEL RICHARD
IPC: C08B1/02
Filed: 1997-10-16
Granted: 2003-08-13
Abstract: This invention describes improvements in or relating to the production of polysaccharide derivatives; more particularly it relates to a method of converting insoluble polysaccharides to a form in which they form part of an anhydrous system in which they may be used as chemical intermediates in the production of derivatives.